Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
NCT03004326 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-01-22
Summary
Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.
Conditions
- Cryoglobulinemic Vasculitis (CV)
- Drug-induced Vasculitis
- Eosinophilic Granulomatosis With Polyangiitis (EGPA)
- IgA Vasculitis
- Isolated Cutaneous Vasculitis
- Granulomatosis With Polyangiitis (GPA)
- Microscopic Polyangiitis (MPA)
- Polyarteritis Nodosa (PAN)
- Urticarial Vasculitis
- Vasculitis
Sponsors & Collaborators
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
collaborator NIH -
National Center for Advancing Translational Sciences (NCATS)
collaborator NIH -
Office of Rare Diseases Research (ORDR)
collaborator UNKNOWN -
Peter Merkel
lead OTHER
Principal Investigators
-
Robert Micheletti, MD · University of Pennsylvania
-
Peter Grayson, MD, MSc · The National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Reproductive Health in Men and Women With Vasculitis
NCT02176070 ·Status: COMPLETED
-
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
NCT00315393 ·Status: COMPLETED
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4
-
Biocollection of Patients With ANCA Associated Vasculitis
NCT05364892 ·Status: RECRUITING ·Phase: NA
-
(PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation
NCT04811365 ·Status: COMPLETED
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
Pediatric Vasculitis Initiative
NCT02006134 ·Status: RECRUITING
-
A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis
NCT01363388 ·Status: COMPLETED ·Phase: PHASE2
-
Educational Needs of Patients With Systemic Vasculitis
NCT02190929 ·Status: COMPLETED
-
VCRC Patient Contact Registry Patient-Reported Data Validation Study
NCT02190942 ·Status: COMPLETED
-
The Registry Study of Takayasu Arteritis in East China
NCT03893136 ·Status: RECRUITING
-
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
NCT00104299 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Journey of Patients With Vasculitis From First Symptom to Diagnosis
NCT03410290 ·Status: COMPLETED
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
NCT00116090 ·Status: COMPLETED
-
Intravenous Immunoglobulin After Relapse in Vasculitis
NCT00307658 ·Status: TERMINATED ·Phase: PHASE3
-
PRO Development for ANCA Associated Vasculitis
NCT01729624 ·Status: UNKNOWN
-
MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis
NCT00301652 ·Status: COMPLETED ·Phase: NA
-
Steroids and Methotrexate to Treat Systemic Vasculitis
NCT00001256 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis
NCT00001541 ·Status: COMPLETED
-
Impact of Vasculitis on Employment and Income
NCT02476292 ·Status: COMPLETED
-
Efficacy Study of Two Treatments in the Remission of Vasculitis
NCT00748644 ·Status: COMPLETED ·Phase: PHASE3
-
Plasma Exchange for Renal Vasculitis
NCT01408836 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome
NCT00716651 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis
NCT04008316 ·Status: UNKNOWN ·Phase: PHASE3